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Purpose: Indicators of aging such as disruption of telomeric function due to shortening may be more frequent in
dysfunctional lacrimal gland. The aims of this study were to 1) determine the viability of quantitative fluorescence in
situ hybridization of telomeres (telo-FISH) for the assessment of telomere length in lacrimal gland in Sjögren and non-
Sjögren syndrome patients; and 2) investigate the relationship between progenitor cell markers and telomere length in
both groups.
Methods: Quantitative fluorescence in situ hybridization with a peptide nucleic acid probe complementary to the telomere
repeat sequence was performed on frozen sections from human lacrimal gland tissues. The mean fluorescence intensity
of telomere spots was automatically quantified by image analysis as relative telomere length in lacrimal gland epithelial
cells. Immunostaining for p63, nucleostemin, ATP-binding cassette, sub-family G, member 2 (ABCG2), and nestin was
also performed.
Results: Telomere intensity in the Sjögren syndrome group (6,785.0±455) was significantly lower than that in the non-
Sjögren  syndrome  group  (7,494.7±477;  p=0.02).  Among  the  samples  from  the  non-Sjögren  syndrome  group,
immunostaining revealed that p63 was expressed in 1–3 acinar cells in each acinar unit and continuously in the basal layer
of duct cells. In contrast, in the Sjögren syndrome group, p63 and nucleostemin showed a lower level of expression.
ABCG2 was expressed in acinar cells in both sjogren and non-Sjogren syndrome.
Conclusions: The results of this study indicate that 1) telo-FISH is a viable method of assessing telomere length in lacrimal
gland, and 2) telomere length in Sjögren syndrome is shorter and associated with lower levels of expression of p63 and
nucleostemin than in non-Sjögren syndrome.
Telomeres are specialized DNA sequences located at the
ends of chromosomes which shorten with each successive
round of cell division. Accumulating evidence indicates that
telomere  length  in  human  somatic  cells  shortens  with
chronological aging [1,2]. The maximum number of possible
cell divisions in a given cell population is fixed. It has been
suggested that this replicative life span, also known as the
“Hayflick  limit,”  is  determined  by  the  telomere  having  a
“critical”  length  [3].  In  human,  telomere  length  has  been
measured  extensively  in  leukocytes  in  relation  to
chronological  aging  [4-6].  Recently,  telomere  length  was
reported to decline with age in mature endothelial cells and to
contribute  to  endothelial  dysfunction  and  atherogenesis
[7-9].
Alteration  in  telomere  length  may  play  a  role  in  the
development of several diseases in human, including cancer
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and  benign  inflammatory  diseases  such  as  idiopathic
pulmonary fibrosis and type 2 diabetes [10-15]. On the other
hand, some studies have indicated that pathological stresses
themselves  may  affect  telomere  shortening,  with
inflammation, for example, reported as one possible cause
[10-12,14],  perhaps  due  to  the  concomitant  increase  in
turnover of cells. Sjögren syndrome is a chronic inflammatory
disease  affecting  the  lacrimal  glands  [16,17].  We
hypothesized  that  telomere  length  shortening  in  lacrimal
gland was related to inflammation of lacrimal gland.
Flores et al. [18] reported that telomeres shorten with age
in  mouse  stem  cells  from  various  tissues,  suggesting  that
telomere loss contributes to stem cell dysfunction with aging.
In addition, they also reported that the longest telomeres were
a general feature of the adult stem cell compartment. Although
no reports have demonstrated the presence of stem cells in
lacrimal gland, tissue-committed progenitor cells are believed
to be present. A recent report showed that injured lacrimal
gland can undergo repair after acinar cells are lost through
apoptosis or autophagy, which is followed by an increase in
the  number  of  stem/progenitor  cells,  stimulation  of
proliferation  and  upregulation  of  the  bone  morphogenetic
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1397protein  3  (BMP7)  pathway  [19].  We  hypothesized  that
progenitor  cell  markers  reported  in  the  corneal  and
conjunctival epithelia, which are of the same origin as the
lacrimal gland during development, were related to telomere
shortening. Therefore we selected p63, nucleostemin, ATP-
binding  cassette,  sub-family  G,  member  2  (ABCG2),  and
nestin as progenitor cell markers for this study. p63 has been
recognized as markers for epithelial cells which have potential
to  proliferate  and  stratified  [20].  Nucleostemin  has  been
reported to be related to small cell size and similar expression
pattern as p63 in corneal epithelium [21,22]. ABCG2 has been
identified as a molecular determinant for bone marrow stem
cells  and  proposed  as  a  universal  marker  for  stem  cells
including corneal limbal epithelial stem cells [23,24]. Nestin
has been used as progenitor marker in the study of lacrimal
gland tissue repair after injury [19,25].
To  the  authors’  knowledge,  no  studies  have  been
published  on  telomere  shortening  in  lacrimal  gland.
Therefore, the aims of this study were to 1) determine the
viability  of  quantitative  fluorescence  in  situ  hybridization
(FISH) of telomeres (telo-FISH) in the assessment of telomere
length in lacrimal gland in Sjögren and non-Sjögren syndrome
patients;  and  2)  investigate  the  relationship  between
progenitor cell markers and telomere length in both groups.
METHODS
Tissue samples: Human tissue samples were obtained with
written  informed  consent  from  patients  treated  at  the
Department  of  Ophthalmology,  Keio  University  Hospital,
Tokyo, Japan. These were in accordance with the principles
expressed in the Declaration of Helsinki. The approval of the
Keio University Ethics Committee was obtained for the use
of human materials for this research. Lacrimal gland biopsy
specimens were collected from 11 patients with dry eye to
determine  the  presence  or  absence  of  Sjögren  syndrome.
Sjögren  syndrome  diagnosis  was  based  on  the  revised
American-European  consensus  criteria  [26,27].  For  the
lacrimal gland study, normal lacrimal gland controls were not
available for ethical reasons. Thus, we used lacrimal glands
biopsy samples that were obtained for diagnostic purposes.
All tissue samples were routinely embedded in Optimal
Cutting Temperature (OCT) compound and stored at −80 °C.
Some of the samples were processed for electron microscopy.
Frozen blocks were sectioned to a thickness of 5 μm and used
for  telo-FISH,  immunohistochemical  analyses  and
hematoxylin and eosin (H&E) staining.
Telomere-FISH analysis: Telo-FISH was performed using a
5′-Cy3-labeled, telomere-specific peptide nucleic acid (PNA)
probe  (5′-CCC  TAA  CCC  TAA  CCC  TAA-3′;  Fasmac,
Kanagawa,  Japan)  as  described  previously  with  some
modifications  [28].  Sections  were  fixed  with  4%
paraformaldehyde (PFA). Slides were incubated with 10 mM
sodium citrate at 80 °C for 30 min. After washing with 1×
PBS, slides were dehydrated using an ethanol series (25%,
50%,  and  100%)  and  air-dried.  Twenty  microliters  Cy3-
labeled telomere-specific PNA probe (2 μg/ml PNA in 70%
formamide buffer with blocking reagent and 10 mM MgSO4)
was added to the sample and denaturation then performed by
incubation  for  15  min  at  95  °C.  Slides  were  incubated
overnight at 37 °C for hybridization. Slides were then washed
in 70% formamide buffer 4× for 15 min each time, followed
by washing in PBS–0.025% Tween-20 four times for 5 min
each. Slides were then dehydrated using an ethanol series and
air-dried.  The  nuclei  were  stained  with  DAPI  (Molecular
Probes, Eugene, OR) for 30 min. The slides were then washed
in PBS for 1 min, briefly dehydrated using the ethanol series
and air-dried. The slides were then mounted with Vectashield
(Vector Laboratories, Burlingame, CA).
Image capturing and analysis: Tissue structure was identified
on H&E-stained adjacent tissue sections before fluorescent
microscopy. For telo-FISH, fluorescence images of DAPI,
and  Cy3  were  recorded  with  an  Olympus  IX-81  inverted
fluorescence  microscope  with  spinning  disk  confocal  unit
(IX81-DSU; Olympus, Tokyo, Japan) equipped with a cooled
CCD ORCA-AG camera (HAMAMATSU, Shizuoka, Japan)
using a UplanSApo 100× /NA.1.40 (Olympus) oil immersion
objective lens. All quantitative image analysis were analyzed
in  MetaMorph  7.6.3.0  software  (MDS  Analytical
Technologies,  Sunnyvale,CA).  Exposure  times  were
optimized  with  respect  to  the  intensities  of  telomere  and
nuclear signals to prevent overexposure/saturation and kept
constant  for  all  slides  to  ensure  consistency  in  intensity
measurement. To avoid differences due to variation in section
thickness, we used slices of the same thickness (5 μm) in all
tissues analyzed.
The DAPI image was used to define the nuclear area and
the Cy3 image was used to quantify telomere fluorescence.
The nuclei of lacrimal gland cells were outlined based on the
DAPI signal, followed by outlining of the telomere signals in
individual nuclei. The intensities of all outlined pixels of both
telomere signals and DAPI were summed respectively on a
per-cell  basis  and  tabulated.  Inflammatory  cells  were
excluded  from  the  analysis.  Telomere  signals  were
standardized with DAPI signals and telomere intensity was
calculated for each nucleus as follows: telomere intensity
(TI)=(sum  of  all  telomere  signal  intensities)/(intensity  of
DAPI signal). Calculation at each step in the analysis was
performed automatically. Ten fields were examined for each
sample,  and  average  telomere  intensity  in  each  sample
calculated.
Statistical analysis: We used the Student t -test to analyze the
results of the clinical findings and the Mann–Whitney U-test
to analyze the results of telo-FISH. A probability value of
p<0.05 was considered to indicate statistical significance.
Immunohistochemistry:  Lacrimal  gland  tissue  slides  were
fixed with 2% paraformaldehyde (PFA; Wako, Osaka, Japan)
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1398for  immunostaining  for  p63  and  nucleostemin.  After
background staining was blocked with 10% normal donkey
serum, samples were treated with the following monoclonal
primary antibodies: anti-p63 (4A4; Calbiochem, A Brand of
EMD Biosciences, Inc., San Diego, CA), anti-nucleostemin
(R&D Systems, Minneapolis, MN), anti-ABCG2 (Chemicon,
Millipore,  Billerica,  MA),  and  anti-nestin  (Santa  Cruz
Biotechnology, Santa Cruz, CA). Samples were then treated
with  Cy3  (Jackson  ImmunoResearch,  West  Grove,  PA)-
conjugated secondary antibodies. Nuclei were counterstained
with 4',6'-diamino-2-phenylindole (1 mg/ml, DAPI; Dojindo
Laboratories, Tokyo, Japan).
Transmission  electron  microscopy:  To  investigate  the
structural  change  of  cells  in  both  groups,  we  performed
transmission  electron  microscopy  analysis.  A  portion
of lacrimal gland tissue was immediately fixed with 2.5%
glutaraldehyde  and  subjected  to  electron  microscopic
examination as described previously [29]. One-micrometer-
thick sections were stained with methylene blue and portions
exhibiting  lacrimal  gland  structure  thin-sectioned  and
examined with an electron microscope (1200 EXII; JEOL,
Tokyo, Japan).
RESULTS
Demographic data: Profiles of the patients are shown in Table
1. A diagnosis of Sjögren syndrome was made in 4 of 11
patients and non-Sjögren syndrome in 7 patients. Patients
ranged in age from 24 to 74 years (mean±SD age, 55.7±14.3
years). No significant difference was found in age of Sjögren
(48.3±17.6 years) and non-Sjögren syndrome (60±11.1 years)
patients.  Sjögren  syndrome  had  significantly  higher  Rose
Bengal score than non-Sjögren syndrome (p<0.001), which
was  the  only  significant  difference  among  the  clinical
parameters between the two groups.
Telomere shortening in Sjögren syndrome: Large numbers of
inflammatory cells invade lacrimal gland tissue in Sjögren
syndrome. Therefore, we selected only locations where acinar
unit structure was well preserved for telo-FISH. In this study,
telo-FISH was successfully performed on fixed frozen tissue
sections. Representative photos are shown in Figure 1A,B.
High levels of Cy3 expression were observed in the nuclei in
lacrimal gland in the non-Sjögren syndrome group, whereas
expression was weak in the Sjögren syndrome group (Figure
1A,B). Telomere intensity in lacrimal gland epithelial cells in
the Sjögren syndrome group (6,785.0±455) was significantly
lower  than  that  in  the  non-Sjögren  syndrome  group
(7,494.7±477; p=0.02, Figure 1C,D).
Progenitor cell markers showed relationship with telomere
shortening: To investigate the relationship between telomere
length  and  progenitor  cell  markers,  we  performed
immunostaining for p63 and nucleostemin. In the non-Sjögren
syndrome group, p63 was expressed in 2–4 acinar cells in each
acinar unit (Figure 2A) and in the basal layer of duct basal
cells continuously (Figure 2B). In contrast, p63 showed a
lower level of expression and was only sparsely expressed in
the basal layer of duct cells in the Sjögren syndrome group
(Figure  2F,G).  Nucleostemin  showed  a  similar  pattern  of
expression as p63, being higher and more regularly expressed
in  the  non-Sjögren  syndrome  group  than  in  the  Sjögren
syndrome group (Figure 2C,H). ABCG2 was expressed in
intercellular  junction  and  cytoplasm  of  most  acinar  unit
regularly in the non-Sjögren syndrome group (Figure 2D).
Whereas acinar unit was decreased in the Sjögren syndrome
group,  and  acinar  unit  with  ABCG2  expression  was  also
decreased (Figure 2I). Nestin was expressed outside the acinar
unit in both group, Elongated cells with nestin expression
were observed more frequently in the SS group, compared
with the non-SS group. Those nestin-positive cells were not
observed uniformly in all locations, but formed cell clusters
at  tissue  damaged  areas  in  the  SS  group  (Figure  2F,J).
Telomere length was shorter and expression of progenitor
TABLE 1. PATIENT'S DEMOGRAPHIC DATA AND TELOMERE INTENSITY.
Number Diagnosis Age Fluorescein
score
Rose bengal score Schirmer
value
Schirmer value with nasal
stimulation
1 SS 24 6 8 2 1
2 SS 49 1 7 5 NA
3 SS 54 2 NA 2 NA
4 SS 66 9 9 5 4
mean±SD   48.3±17.6 4.5±3.6 8.0±1.0 3.5±1.7 2.5±2.1
5 Non-SS 42 1 4 2 35
6 Non-SS 54 6 2 8 NA
7 Non-SS 54 0 2 2 16
8 Non-SS 59 3 0 5 7
9 Non-SS 66 0 0 4 24
10 Non-SS 71 2 NA 4 2
11 Non-SS 74 0 2 4 4
mean±SD   60.0±11.1 1.7±2.2 1.7±1.5 4.1±2.0 14.7±12.9
               SS, Sjögren syndrome; Non-SS, Non-Sjögren syndrome; NA, Not applicable; SD, standard deviation.
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1399markers  weaker  or  non-existent  in  the  Sjögren  syndrome
group.
Electron microscopy findings: To determine ultrastructural
changes in lacrimal gland, we analyzed samples using electron
microscopy. Electron microscopy revealed that the structure
of each lacrimal acinar unit was compact and uniform in the
non-Sjögren  syndrome  group.  Myoepithelial  cells  were
smooth in shape (Figure 3B). Mild acinar atrophy and fibrosis
were  observed  more  frequently  in  the  Sjögren  syndrome
group  (Figure  3E).  Infiltration  of  inflammatory  cells  was
observed in both groups, being particularly marked in the
Sjögren syndrome group. High magnification revealed that
the structure of mitochondrial cristae was severely damaged
and  swollen  in  the  Sjögren  syndrome  group  (Figure  3F)
compared to that in the non-Sjögren syndrome group (Figure
3C), indicating that mitochondrial damage may be related to
Sjögren syndrome.
DISCUSSION
In this study, we successfully measured telomere intensity in
lacrimal gland epithelial cells by telo-FISH and investigated
relative telomere length in each cell. We believe that this is
the first report of a telomere length analysis in lacrimal gland.
The results showed that the telomeres in lacrimal gland
cells in the Sjögren syndrome group were significantly shorter
than  those  in  the  non-Sjögren  syndrome  group  (p=0.02).
Patchy invasion by inflammatory cells and the destruction of
lacrimal  gland  structure  were  observed  frequently  in  the
Sjögren syndrome group. It should be noted that these results
were obtained even though we selected only those areas in
which  acinar  unit  structure  was  preserved  for  telo-FISH.
Furthermore, even though the clinical findings were similar
between the two groups, telomere length showed a significant
difference.
These results suggest that telomere length is related to
severe dry eye diseases where normal lacrimal gland function
has been disrupted by chronic inflammation. Recently, it has
been reported that renal failure shortens cardiac telomeres,
and  that  short  telomeres  are  a  risk  factor  for  idiopathic
pulmonary fibrosis [10,11]. The present results are consistent
with  these  earlier  reports  indicating  a  strong  association
between  organ  dysfunction  and  telomere  shortening,
suggesting telomere shortening as a risk factor for lacrimal
gland  dysfunction  as  well.  Telomere  shortening  has  been
reported in several inflammatory diseases such as vascular
disease,  type  2  diabetes,  Fanconi  anemia,  and  ataxia
teleangiectasia  [12-15].  Lacrimal  gland  epithelial  cell
turnover was not clearly defined until recently, however, so
further  study  is  necessary  to  investigate  the  relationship
between telomere length and inflammation in this tissue.
Progenitor cell marker expression (p63, nucleostemin,
and ABCG2) was weaker in the Sjögren syndrome group than
in  non-Sjögren  syndrome  group.  p63  is  often  used  as  a
progenitor cell marker for keratinocytes and corneal epithelial
cells with high proliferative potential [20]. Nucleostemin has
been  reported  in  proliferating  cells  in  various  tissues,
including bone marrow, and may be used as a progenitor
marker  for  stratified  epithelial  cells  [21,22].  ABCG2  and
Figure  1.  Telomere  shortening  in
Sjögren syndrome. Representative telo-
FISH  photograph  of  non-Sjögren
syndrome  (A)  and  Sjögren  syndrome
(B) lacrimal glands. Scatter plot of age
and  telomere  intensity  (TI;  C).
Comparison  of  average  telomere
intensity  in  Sjögren  and  non-Sjögren
syndrome  groups  demonstrated  that
telomeres were significantly shorter in
Sjögren syndrome group (D; p=0.02).
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1400nestin have been recognized as one of progenitor cell markers
in  adult  tissue.  Surprisingly,  nestin-positve  cells  were
observed more frequently in the Sjögren syndrome, which
maybe  partially  explained  that  nestin  expressed  only  in
repairing/regeneration  location,  but  not  in  quiescent  cells
[19,25]. These results suggest that telomere length shortening
in lacrimal progenitor cells indicates the pathophysiological
conditions necessary for development of Sjögren syndrome.
Although most tissues are known to have their own tissue-
specific stem cells, the existence of stem cells in lacrimal
gland has yet to be proven. The results of telo-FISH may
indicate the existence of progenitor cells in lacrimal gland
[30].  Further  investigation  is  needed  to  characterize  the
progenitor cells and their homeostasis in lacrimal gland.
Electron  microscopy  revealed  that  the  structure  of
mitochondrial cristae was severely damaged in the Sjögren
syndrome group (Figure 3F) compared to in the non-Sjögren
syndrome group (Figure 3C). There were some reports about
the  associations  among  telomere  length,  mitochondrial
function and oxidative stress [31-36]. Mitochondria are the
most important source of reactive oxygen species in cells
under physiologic conditions, and premature senescent cells
sorted  from  young  cultures  displayed  mitochondrial
dysfunction, increased oxidative stress and short telomeres
[31].  Another  report  showed  that  improvement  in
mitochondrial function results in less telomeric damage and
slower  telomere  shortening,  while  telomere-dependent
growth  arrest  is  associated  with  increased  mitochondrial
dysfunction [32]. Furthermore, telomere-shortening rate and
cell replicative life spans can be greatly modified by DNA-
damaging  oxidative  stress  [5],  which  has  been  shown  to
accelerate telomere shortening during DNA replication [37].
The mitochondrial structural changes observed in this study
may contribute to the increase in oxidative stress induced by
Sjögren  syndrome.  However  the  relationship  between
mitochondrial damage and telomere shortening was not clear
in this study, and further study was necessary to clarify the
molecular mechanism. The results of this study indicate that
1) telo-FISH is a viable method of assessing telomere length
in lacrimal gland; and 2) telomere length in Sjögren syndrome
Figure 2. Immunostaining for progenitor markers. In non-Sjögren syndrome, p63 (red) was expressed in 2–4 cells in each acinar unit (A) and
all ductal basal cells (B; case 7). In Sjögren syndrome, p63 was weakly expressed with irregular pattern. (case 2; F, G). Nucleostemin was
expressed with a similar pattern in non-Sjögren syndrome (case 7; C) and Sjögren syndrome (case 2; H). Nuclei were counterstained with
DAPI (blue). ABCG2 (red) was expressed in intercellular junction and cytoplasm in acinar unit (F, I), and weaker in Sjögren syndrome. Nestin
was expressed strongly in some location in Sjögren syndrome (E, J). Scale bars indicate 50 μm (A-C, E-H, J) and 20 μm (D, I), SS=Sjögren
syndrome, non-SS=non Sjögren syndrome.
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1401is  shorter  than  in  non-Sjögren  syndrome,  possibly  due  to
acceleration of the cell cycle to maintain lacrimal gland cell
homeostasis, and associated with lower levels of expression
of p63 and nucleostemin.
Taken together, this suggests that dysfunction in lacrimal
gland may be related to epithelial cell telomere shortening.
Further study is needed, however, to clarify the underlying
molecular mechanism.
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